Alpha 2.0
Login Register
» Authors » Joaniter I Nankabirwa

Joaniter I Nankabirwa

Explore the profile of Joaniter I Nankabirwa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 1015
Followers 0
Related Specialties
Tropical Medicine
General Medicine
Science
Top 10 Co-Authors
Moses R Kamya
Grant Dorsey
Emmanuel Arinaitwe
Sarah G Staedke
Philip J Rosenthal
John Rek
Bryan Greenhouse
Jessica Briggs
Isabel Rodriguez-Barraquer
Chris Drakeley
Published In
Malar J
Am J Trop Med Hyg
PLoS One
PLOS Glob Public Health
Clin Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Evaluating the impact of two next-generation long-lasting insecticidal nets on malaria incidence in Uganda: an interrupted time-series analysis using routine health facility data
Epstein A, Gonahasa S, Namuganga J, Nassali M, Maiteki-Sebuguzi C, Nabende I, et al.
BMJ Glob Health . 2025 Mar; 10(3). PMID: 40068926
Introduction: Malaria remains a significant public health challenge globally, particularly in sub-Saharan Africa, where progress has stalled in recent years. Long-lasting insecticidal nets (LLINs) are a critical preventive tool against...
2.
LLIN Evaluation in Uganda Project (LLINEUP2) - Effect of long-lasting insecticidal nets (LLINs) treated with pyrethroid plus pyriproxyfen vs LLINs treated with pyrethroid plus piperonyl butoxide in Uganda: A cluster-randomised trial
Gonahasa S, Namuganga J, Nassali M, Maiteki-Sebuguzi C, Nabende I, Epstein A, et al.
PLOS Glob Public Health . 2025 Feb; 5(2):e0003558. PMID: 40009611
Long-lasting insecticidal nets (LLINs) are the cornerstone of malaria control, but their effectiveness is threatened by pyrethroid resistance. We embedded a pragmatic, cluster-randomised trial into Uganda's national LLIN distribution campaign...
3.
Assessment of different genotyping markers and algorithms for distinguishing Plasmodium falciparum recrudescence from reinfection in Uganda
Mwesigwa A, Golumbeanu M, Jones S, Cantoreggi S, Musinguzi B, Nankabirwa J, et al.
Sci Rep . 2025 Feb; 15(1):4375. PMID: 39910229
Antimalarial therapeutic efficacy studies are vital for monitoring drug efficacy in malaria-endemic regions. The WHO recommends genotyping polymorphic markers including msp-1, msp-2, and glurp for distinguishing recrudescences from reinfections. Recently,...
4.
Temporal changes in Plasmodium falciparum genetic diversity and multiplicity of infection across three areas of varying malaria transmission intensities in Uganda
Mwesigwa A, Kiwuwa S, Musinguzi B, Kawalya H, Katumba J, Baguma A, et al.
Trop Med Health . 2024 Dec; 52(1):103. PMID: 39734236
Background: Malaria is a significant public health challenge in Uganda, with Plasmodium falciparum (P. falciparum) responsible for most of malaria infections. The high genetic diversity and multiplicity of infection (MOI)...
5.
Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study
Bagala I, Namuganga J, Nayebare P, Cuu G, Katairo T, Nabende I, et al.
PLoS One . 2024 Dec; 19(12):e0312554. PMID: 39715211
Background: Understanding COVID-19's impact on children is vital for public health policy, yet age-specific data is scarce, especially in Uganda. This study examines SARS-CoV-2 seroprevalence and risk factors among Ugandan...
6.
Optimizing the Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Diagnostic Tests for the Timely Detection of and Response to COVID-19 in Schools and Markets in Uganda
Mulondo J, Nayiga S, Nuwagaba W, Nayebare P, Namuganga J, Ssewanyana I, et al.
Am J Trop Med Hyg . 2024 Nov; PMID: 39591649
The early detection and management of infections is crucial to control epidemics. We evaluated the feasibility and utility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen rapid diagnostic tests...
7.
Plasmodium falciparum genetic diversity and multiplicity of infection among asymptomatic and symptomatic malaria-infected individuals in Uganda
Mwesigwa A, Ocan M, Cummings B, Musinguzi B, Kiyaga S, Kiwuwa S, et al.
Trop Med Health . 2024 Nov; 52(1):86. PMID: 39543779
Background: Plasmodium falciparum (P. falciparum) remains a significant public health challenge globally, especially in sub-Saharan Africa (SSA), where it accounts for 99% of all malaria infections. The outcomes of P....
8.
Natural killer cell antibody-dependent cellular cytotoxicity to is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission
Tukwasibwe S, Lewis S, Taremwa Y, van der Ploeg K, Press K, Ty M, et al.
Clin Transl Immunology . 2024 Nov; 13(11):e70005. PMID: 39493859
Objectives: Natural killer (NK) cells make important contributions to anti-malarial immunity through antibody-dependent cellular cytotoxicity (ADCC), but the role of different components of this pathway in promoting NK cell activation...
9.
Effect of the second and third COVID-19 pandemic waves on routine outpatient malaria indicators and case management practices in Uganda: an interrupted time series analysis
Mukisa P, Kitutu F, Mpimbaza A, Okiring J, Kalyango J, Nankabirwa J
Malar J . 2024 Oct; 23(1):323. PMID: 39472901
Background: Reports on the impact of COVID-19 pandemic on the quality of malaria care and burden in sub Saharan Africa have provided a mixed picture to date. The impact of...
10.
Operational Research to Support Rapid Evidence-Based Responses to Outbreaks: Learnings from COVID-19
Hoppe A, Dani P, Mwangoka G, Vreden S, Breton G, Ateudjieu J, et al.
Am J Trop Med Hyg . 2024 Oct; PMID: 39378872
During the COVID-19 pandemic, the need for making testing readily available was recognized as an important factor for individuals to help make informed decisions, including to isolate or seek care,...